The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Administration, Intranasal

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Administration, Intranasal


Psychiatry related information on Administration, Intranasal


High impact information on Administration, Intranasal


Chemical compound and disease context of Administration, Intranasal


Biological context of Administration, Intranasal


Anatomical context of Administration, Intranasal


Associations of Administration, Intranasal with chemical compounds


Gene context of Administration, Intranasal


Analytical, diagnostic and therapeutic context of Administration, Intranasal


  1. Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis. Wright, J.M., Wall, R.A., Perry, T.L., Paty, D.W. N. Engl. J. Med. (1984) [Pubmed]
  2. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. Hayden, F.G., Treanor, J.J., Betts, R.F., Lobo, M., Esinhart, J.D., Hussey, E.K. JAMA (1996) [Pubmed]
  3. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. Lefort, J., Nahori, M.A., Ruffie, C., Vargaftig, B.B., Pretolani, M. J. Clin. Invest. (1996) [Pubmed]
  4. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. Knapp, S., Florquin, S., Golenbock, D.T., van der Poll, T. J. Immunol. (2006) [Pubmed]
  5. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. Langdon, C., Kerr, C., Tong, L., Richards, C.D. J. Immunol. (2003) [Pubmed]
  6. Intranasal activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in conscious dogs. Nelson, A.H., Walker, R.F., Codd, E.E., Barone, F.C. Life Sci. (1991) [Pubmed]
  7. Possible role of prostaglandins in pathogenesis of nocturnal enuresis in children. Kuznetsova, A.A., Shakhmatova, E.I., Prutskova, N.P., Natochin, Y.V. Scandinavian journal of urology and nephrology. (2000) [Pubmed]
  8. Improvements in the selective perception and training of rats using an original analog of the C-terminal fragment of vasopressin. Ponomareva, N.S., Voskresenskaya, O.G., Kamenskii, A.A., Golubovich, V.P., Ashmarin, I.P. Neurosci. Behav. Physiol. (2000) [Pubmed]
  9. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. Sugimoto, T., Ishikawa, Y., Yoshimoto, T., Hayashi, N., Fujimoto, J., Nakanishi, K. J. Exp. Med. (2004) [Pubmed]
  10. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. Tian, J., Atkinson, M.A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P.V., Kaufman, D.L. J. Exp. Med. (1996) [Pubmed]
  11. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. Auricchio, A., O'Connor, E., Weiner, D., Gao, G.P., Hildinger, M., Wang, L., Calcedo, R., Wilson, J.M. J. Clin. Invest. (2002) [Pubmed]
  12. Immunomodulation by mucosal gene transfer using TGF-beta DNA. Kuklin, N.A., Daheshia, M., Chun, S., Rouse, B.T. J. Clin. Invest. (1998) [Pubmed]
  13. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Blease, K., Schuh, J.M., Jakubzick, C., Lukacs, N.W., Kunkel, S.L., Joshi, B.H., Puri, R.K., Kaplan, M.H., Hogaboam, C.M. Am. J. Pathol. (2002) [Pubmed]
  14. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis. Seif, S.M., Zenser, T.V., Ciarochi, F.F., Davis, B.B., Robinson, A.G. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  15. Hypersensitivity reactions after respiratory sensitization: effect of intranasal peptides containing T-cell epitopes. Jarnicki, A.G., Tsuji, T., Thomas, W.R. J. Allergy Clin. Immunol. (2002) [Pubmed]
  16. Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism. Klingmüller, D., Schweikert, H.U. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  17. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis. McNeely, W., Wiseman, L.R. Drugs (1998) [Pubmed]
  18. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. Bagnasco, M., Mariani, G., Passalacqua, G., Motta, C., Bartolomei, M., Falagiani, P., Mistrello, G., Canonica, G.W. J. Allergy Clin. Immunol. (1997) [Pubmed]
  19. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Cass, L.M., Efthymiopoulos, C., Bye, A. Clinical pharmacokinetics. (1999) [Pubmed]
  20. The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis. Albert, D.H., Malo, P.E., Tapang, P., Shaughnessy, T.K., Morgan, D.W., Wegner, C.D., Curtin, M.L., Sheppard, G.S., Xu, L., Davidsen, S.K., Summers, J.B., Carter, G.W. J. Pharmacol. Exp. Ther. (1998) [Pubmed]
  21. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice. Taylor, G., Stott, E.J., Wertz, G., Ball, A. J. Gen. Virol. (1991) [Pubmed]
  22. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats. Chow, H.H., Anavy, N., Villalobos, A. Journal of pharmaceutical sciences. (2001) [Pubmed]
  23. Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. Astori, M., von Garnier, C., Kettner, A., Dufour, N., Corradin, G., Spertini, F. J. Immunol. (2000) [Pubmed]
  24. Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF. Ohta, K., Yamashita, N., Tajima, M., Miyasaka, T., Nakano, J., Nakajima, M., Ishii, A., Horiuchi, T., Mano, K., Miyamoto, T. J. Allergy Clin. Immunol. (1999) [Pubmed]
  25. Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice. Moffatt, J.D., Jeffrey, K.L., Cocks, T.M. Am. J. Respir. Cell Mol. Biol. (2002) [Pubmed]
  26. Mutation of luxS of Streptococcus pneumoniae affects virulence in a mouse model. Stroeher, U.H., Paton, A.W., Ogunniyi, A.D., Paton, J.C. Infect. Immun. (2003) [Pubmed]
  27. In vivo protein transduction to the CNS. Loftus, L.T., Li, H.F., Gray, A.J., Hirata-Fukae, C., Stoica, B.A., Futami, J., Yamada, H., Aisen, P.S., Matsuoka, Y. Neuroscience (2006) [Pubmed]
  28. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. Tran, P.L., Weinbach, J., Opolon, P., Linares-Cruz, G., Reynes, J.P., Grégoire, A., Kremer, E., Durand, H., Perricaudet, M. J. Clin. Invest. (1997) [Pubmed]
  29. Cerebral neurogenesis is induced by intranasal administration of growth factors. Jin, K., Xie, L., Childs, J., Sun, Y., Mao, X.O., Logvinova, A., Greenberg, D.A. Ann. Neurol. (2003) [Pubmed]
  30. Cerebral vasculitis associated with cocaine abuse. Fredericks, R.K., Lefkowitz, D.S., Challa, V.R., Troost, B.T. Stroke (1991) [Pubmed]
  31. Plasma gonadotropin and gonadotropin-releasing hormone levels after intranasal administration of gonadotropin releasing hormone. Katz, M., Pimstone, B.L., Carr, P.J., Hendricks, S. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
  32. Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant. Gorziglia, M., Kapikian, A.Z. J. Virol. (1992) [Pubmed]
  33. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. Marinaro, M., Boyaka, P.N., Jackson, R.J., Finkelman, F.D., Kiyono, H., Jirillo, E., McGhee, J.R. J. Immunol. (1999) [Pubmed]
  34. Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children. Ghigo, E., Procopio, M., Bellone, J., Mazza, E., Mucci, M., Boghen, M.F., Müller, E.E., Camanni, F. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  35. Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans. Perras, B., Schultes, B., Behn, B., Dodt, C., Born, J., Fehm, H.L. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  36. No defect in T-cell priming, secondary response, or tolerance induction in response to inhaled antigens in Fms-like tyrosine kinase 3 ligand-deficient mice. Walzer, T., Brawand, P., Swart, D., Tocker, J., De Smedt, T. J. Allergy Clin. Immunol. (2005) [Pubmed]
  37. Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Chabot, S., Salez, L., McCormack, F.X., Touqui, L., Chignard, M. Am. J. Respir. Cell Mol. Biol. (2003) [Pubmed]
  38. Transplantation tolerance induced by intranasal administration of HY peptides. Chai, J.G., James, E., Dewchand, H., Simpson, E., Scott, D. Blood (2004) [Pubmed]
  39. Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis. Joosten, L.A., Coenen-de Roo, C.J., Helsen, M.M., Lubberts, E., Boots, A.M., van den Berg, W.B., Miltenburg, A.M. Arthritis Rheum. (2000) [Pubmed]
  40. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. Jakubzick, C., Choi, E.S., Joshi, B.H., Keane, M.P., Kunkel, S.L., Puri, R.K., Hogaboam, C.M. J. Immunol. (2003) [Pubmed]
  41. Comparison of intravenous and intranasal administration of epinephrine during CPR in a canine model. Bleske, B.E., Warren, E.W., Rice, T.L., Shea, M.J., Amidon, G., Knight, P. Annals of emergency medicine. (1992) [Pubmed]
  42. Absorption of clonazepam after intranasal and buccal administration. Schols-Hendriks, M.W., Lohman, J.J., Janknegt, R., Korten, J.J., Merkus, F.W., Hooymans, P.M. British journal of clinical pharmacology. (1995) [Pubmed]
WikiGenes - Universities